• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用佐剂联合重组核蛋白经鼻内免疫的小鼠鼻内部位,Th1细胞加速流感病毒清除。

Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.

作者信息

Tamura S, Miyata K, Matsuo K, Asanuma H, Takahashi H, Nakajima K, Suzuki Y, Aizawa C, Kurata T

机构信息

Department of Pathology, National Institute of Health, Tokyo, Japan.

出版信息

J Immunol. 1996 May 15;156(10):3892-900.

PMID:8621928
Abstract

The protective roles of influenza viral nucleoprotein (NP), together with the cellular mechanism of the protection in the nasal site, were examined in BALB/c mice immunized intranasally with an adjuvant (cholera toxin B subunit containing 0.2% of the whole toxin)-combined A or B virus recombinant NP. The NP-immune mice, when challenged intranasally with a sublethal dose of the virus 3 wk after immunization, had accelerated virus clearance from the nasal site in both an influenza type-specific and a nonspecific manner, as shown by the protection from high morbidity from the second day after challenge. Both type-specific and nonspecific acceleration of recovery was confirmed by the increased survival rate after challenge with a lethal dose of virus in mice immunized and boosted with adjuvant-combined NP. The acceleration of nasal virus clearance was accompanied with acceleration of type-specific systemic delayed-type hypersensitivity (DTH) and with IFN-gamma production by nasal lymphocytes. The nasal lymphocytes from the immunized and challenged mice generated a significantly high level of DTH when transferred locally, but no class I MHC-restricted CTL response. Moreover, nasal CD4+ T cells, induced by NP immunization and increased in number by the subsequent challenge, were involved in the accelerated IFN-gamma production. These results suggest that nasal Th1 cells, capable of producing IFN-gamma and mediating DTH, are involved in the type-specific acceleration of recovery from influenza after challenge in mice immunized intranasally with adjuvant-combined NP, although the nonspecific mechanism of accelerated recovery remains to be solved.

摘要

用佐剂(含0.2%全毒素的霍乱毒素B亚单位)联合A或B病毒重组核蛋白(NP)经鼻内免疫BALB/c小鼠,研究流感病毒核蛋白(NP)的保护作用及其在鼻部位的细胞保护机制。NP免疫小鼠在免疫后3周经鼻内用亚致死剂量病毒攻击时,从攻击后第二天起对高发病率有保护作用,表明其以流感病毒型特异性和非特异性方式加速了病毒从鼻部位的清除。用佐剂联合NP免疫和加强免疫的小鼠,在经致死剂量病毒攻击后存活率增加,证实了恢复的型特异性和非特异性加速。鼻病毒清除的加速伴随着型特异性全身迟发型超敏反应(DTH)的加速和鼻淋巴细胞产生干扰素-γ。免疫和攻击小鼠的鼻淋巴细胞局部转移时产生显著高水平的DTH,但无I类MHC限制性CTL反应。此外,NP免疫诱导并在随后攻击中数量增加的鼻CD4+T细胞参与了干扰素-γ产生的加速。这些结果表明,能够产生干扰素-γ并介导DTH的鼻Th1细胞参与了用佐剂联合NP经鼻内免疫的小鼠在攻击后流感恢复的型特异性加速,尽管加速恢复的非特异性机制仍有待解决。

相似文献

1
Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein.用佐剂联合重组核蛋白经鼻内免疫的小鼠鼻内部位,Th1细胞加速流感病毒清除。
J Immunol. 1996 May 15;156(10):3892-900.
2
Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. II. Protection from influenza infection and mechanism of protection.甲型流感病毒重组核蛋白诱导的抗病毒免疫。II. 预防流感感染及保护机制。
Immunology. 1990 Oct;71(2):202-7.
3
Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit.用霍乱毒素B亚基经鼻接种三价灭活疫苗所提供的针对流感病毒感染的交叉保护作用。
J Immunol. 1992 Aug 1;149(3):981-8.
4
Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoprotein.鼻腔内给予重组核蛋白可预防多种甲型流感病毒亚型感染
Arch Virol. 2010 Nov;155(11):1765-75. doi: 10.1007/s00705-010-0756-3. Epub 2010 Jul 22.
5
Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge.DNA疫苗诱导的CTL前体频率的剂量依赖性及其与抗流感病毒攻击的保护性免疫的相关性。
J Immunol. 1999 Apr 1;162(7):4163-70.
6
Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier.甲型流感病毒重组核蛋白诱导的抗病毒免疫。III. 以减毒鼠伤寒沙门氏菌作为活载体将重组核蛋白递送至免疫系统。
Immunology. 1990 Aug;70(4):540-6.
7
Protective effect of nasal immunization of influenza virus hemagglutinin with recombinant cholera toxin B subunit as a mucosal adjuvant in mice.以重组霍乱毒素B亚基作为黏膜佐剂经鼻腔免疫流感病毒血凝素对小鼠的保护作用
Microbiol Immunol. 2008 Feb;52(2):55-63. doi: 10.1111/j.1348-0421.2008.00010.x.
8
Live varicella vaccine polarizes the mucosal adjuvant action of cholera toxin or its B subunit on specific Th1-type helper T cells with a single nasal coadministration in mice.在小鼠中,活水痘疫苗与霍乱毒素或其B亚基通过单次鼻腔联合给药,可使特定的Th1型辅助性T细胞极化,发挥黏膜佐剂作用。
J Med Virol. 2003 Jun;70(2):329-35. doi: 10.1002/jmv.10399.
9
Antiviral immunity induced by recombinant nucleoprotein of influenza A virus. I. Characteristics and cross-reactivity of T cell responses.甲型流感病毒重组核蛋白诱导的抗病毒免疫。I. T细胞应答的特征及交叉反应性。
J Immunol. 1988 Dec 1;141(11):3980-7.
10
Nasal immunization of nonhuman primates with simian immunodeficiency virus p55gag and cholera toxin adjuvant induces Th1/Th2 help for virus-specific immune responses in reproductive tissues.用猿猴免疫缺陷病毒p55gag和霍乱毒素佐剂对非人灵长类动物进行鼻腔免疫,可诱导生殖组织中针对病毒的特异性免疫反应产生Th1/Th2辅助。
J Immunol. 1998 Dec 1;161(11):5952-8.

引用本文的文献

1
Ectopic germinal centers in the nasal turbinates contribute to B cell immunity to intranasal viral infection and vaccination.鼻甲中的异位生发中心有助于B细胞对鼻内病毒感染和疫苗接种产生免疫。
Proc Natl Acad Sci U S A. 2025 Mar 25;122(12):e2421724122. doi: 10.1073/pnas.2421724122. Epub 2025 Mar 20.
2
Protective Efficacy of a Mucosal Influenza Vaccine Formulation Based on the Recombinant Nucleoprotein Co-Administered with a TLR2/6 Agonist BPPcysMPEG.基于重组核蛋白与TLR2/6激动剂BPPcysMPEG联合给药的粘膜流感疫苗制剂的保护效力
Pharmaceutics. 2023 Mar 10;15(3):912. doi: 10.3390/pharmaceutics15030912.
3
Bacterial AB toxins and host-microbe interactions.
细菌 AB 毒素与宿主-微生物相互作用。
Adv Microb Physiol. 2022;81:67-109. doi: 10.1016/bs.ampbs.2022.06.002. Epub 2022 Jul 18.
4
Advances in Infectious Disease Vaccine Adjuvants.传染病疫苗佐剂的进展
Vaccines (Basel). 2022 Jul 13;10(7):1120. doi: 10.3390/vaccines10071120.
5
Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo.通用流感疫苗:在体内实现广泛交叉保护的进展。
Am J Epidemiol. 2018 Dec 1;187(12):2603-2614. doi: 10.1093/aje/kwy145.
6
M2e-tetramer-specific memory CD4 T cells are broadly protective against influenza infection.M2e-tetramer 特异性记忆 CD4 T 细胞广泛地对流感感染具有保护作用。
Mucosal Immunol. 2018 Jan;11(1):273-289. doi: 10.1038/mi.2017.14. Epub 2017 Mar 1.
7
Self-Amplifying mRNA Vaccines Expressing Multiple Conserved Influenza Antigens Confer Protection against Homologous and Heterosubtypic Viral Challenge.表达多种保守流感抗原的自我扩增mRNA疫苗可抵御同源和异亚型病毒攻击。
PLoS One. 2016 Aug 15;11(8):e0161193. doi: 10.1371/journal.pone.0161193. eCollection 2016.
8
Identification and Analysis of Natural Killer Cells in Murine Nasal Passages.小鼠鼻腔中自然杀伤细胞的鉴定与分析
PLoS One. 2015 Nov 17;10(11):e0142920. doi: 10.1371/journal.pone.0142920. eCollection 2015.
9
Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice.在小鼠中通过口服共同给予表达核蛋白的乳酸乳球菌并佐以霍乱毒素B亚基,对多种流感病毒产生广泛的保护性免疫。
Microb Cell Fact. 2015 Aug 5;14:111. doi: 10.1186/s12934-015-0287-4.
10
Cross-protection against influenza virus infection by intranasal administration of nucleoprotein-based vaccine with compound 48/80 adjuvant.通过鼻内接种基于核蛋白的疫苗与复合48/80佐剂实现对流感病毒感染的交叉保护。
Hum Vaccin Immunother. 2015;11(2):397-406. doi: 10.4161/21645515.2014.995056.